epilepsiaEpilepsy and paroxysmal conditionsЭпилепсия и пароксизмальные состояния2077-83332311-4088IRBIS LLCepilepsia-287Research ArticleORIGINAL ARTICLESОРИГИНАЛЬНЫЕ СТАТЬИEXPERIENCE OF TREATMENT WITH GENERIC LAMOTRIDJIN IN DIFFERENT FORMS OF EPILEPSY (The results of focus observation in out-patient clinics network of Moscow city public healthcare services)ОПЫТ ПРИМЕНЕНИЯ ГЕНЕРИЧЕСКОГО ЛАМОТРИДЖИНА ПРИ РАЗЛИЧНЫХ ФОРМАХ ЭПИЛЕПСИИ (результаты фокусного наблюдения в учреждениях амбулаторной сети городского здравоохранения г. Москвы)БадалянО. Л.BadalyanO. L.БогомазоваМ. А.BogomazovaM. A.ЖуравлеваИ. И.ZhuravlevaI. I.ИсмаиловА. М.IsmailovA. M.АртемоваИ. Ю...КомельковаЕ. Г.KomelkovaE. G.ЛесинкерЛ. Н.LesinkerL. N.ЛогвиновЮ. И.LogvinovYu. I.ОтческаяО. В.OtcheskayaO. V.ПетровС. В.PetrovS. V.СоломатинЮ. В.SolomatinYu. V.ТеплышеваА. М.TeplyshevaA. M.УдовиченкоТ. Н.UdovuchenkoT. N.ХромыхЕ. А.KhromykhA. E.ЧукановаА. С.ChukanovaA. S.ЛебедеваА. В.LebedevaA. V.БурдС. Г.BurdS. G.БойкоА. Н.BoikoA. N.Городские поликлиники г. МосквыРоссияCity polyclinics, MoscowRussian FederationГБОУ ВПО РНИМУ им. Н.И. Пирогова, МоскваРоссияGBOU VPO RNIMU named after N.I. Pirogov, MoscowRussian Federation201207092016444048Copyright © Badalyan O.L., Bogomazova M.A., Zhuravleva I.I., Ismailov A.M., . ..Ю., Komelkova E.G., Lesinker L.N., Logvinov Y.I., Otcheskaya O.V., Petrov S.V., Solomatin Y.V., Teplysheva A.M., Udovuchenko T.N., Khromykh A.E., Chukanova A.S., Lebedeva A.V., Burd S.G., Boiko A.N., 20162016Бадалян О.Л., Богомазова М.А., Журавлева И.И., Исмаилов А.М., Артемова И.Ю., Комелькова Е.Г., Лесинкер Л.Н., Логвинов Ю.И., Отческая О.В., Петров С.В., Соломатин Ю.В., Теплышева А.М., Удовиченко Т.Н., Хромых Е.А., Чуканова А.С., Лебедева А.В., Бурд С.Г., Бойко А.Н.Badalyan O.L., Bogomazova M.A., Zhuravleva I.I., Ismailov A.M., . .., Komelkova E.G., Lesinker L.N., Logvinov Y.I., Otcheskaya O.V., Petrov S.V., Solomatin Y.V., Teplysheva A.M., Udovuchenko T.N., Khromykh A.E., Chukanova A.S., Lebedeva A.V., Burd S.G., Boiko A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.epilepsia.su/jour/article/view/287

Focused observational study on efficacy, tolerability and quality of life in adult patients with different forms of epilepsy taking combined therapy with lamotrigine (Sazar). 32 patients (19 men and 13 women), 23-79 years old with focal forms (cryptogenic and symptomatic) epilepsy with different disease duration and presence of of different type and etiology seizures were enrolled into the study. Patients having been taken various antiepileptic drugs in monotherapy with different efficacy degree were observed. Patients sample included 20 patients, receiving valproic acid in various dosages and 12 patients, receiving topiramate. Sazar was added as a second drug with initial dosage of 25 mg daily. Results of focused observation allow us to make conclusion of possible expedience of Sazar indication, especially in patients in whom therapy with valproic acid is less effective.

эпилепсиякомбинированная терапияламотриджинСейзарepilepsycombined therapylamotrigineSazar.ReferencesДробижев М.Ю. Психиатрия и психофармакотерпия. 2007; 9 (3).Дробижев М.Ю. Психиатрия и психофармакотерпия. 2007; 9 (3).Borgheini G. Clin Ther. 2003 Jun; 25(6): 1578-92.Borgheini G. Clin Ther. 2003 Jun; 25(6): 1578-92.Duh M.S., Andermann F., Paradis P.E., Weiner J., Manjunath R., Cr mieux P.Y. Dis Manag. 2007 Aug; 10 (4): 216-25.Duh M.S., Andermann F., Paradis P.E., Weiner J., Manjunath R., Cr mieux P.Y. Dis Manag. 2007 Aug; 10 (4): 216-25.Bialer M. Epilepsia. 2007 Oct; 48 (10): 1825-32.Bialer M. Epilepsia. 2007 Oct; 48 (10): 1825-32.Andermann F., Duh M.S., Gosselin A., Paradis P.E. Epilepsia. 2007 Mar; 48 (3): 464-9.Andermann F., Duh M.S., Gosselin A., Paradis P.E. Epilepsia. 2007 Mar; 48 (3): 464-9.Chow S.C., Liu J.J. Biopharm Stat. 1997 Mar; 7 (1): 97-111.Chow S.C., Liu J.J. Biopharm Stat. 1997 Mar; 7 (1): 97-111.Heaney D.C., Sander J.W. Lancet Neurol. 2007 May; 6 (5): 465-8.Heaney D.C., Sander J.W. Lancet Neurol. 2007 May; 6 (5): 465-8.Lee C.Y., Fu W.M., Chen C.C., Su M.J., Liou H.H. Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia. 2008 May; 49 (5): 888-97.Lee C.Y., Fu W.M., Chen C.C., Su M.J., Liou H.H. Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia. 2008 May; 49 (5): 888-97.Liu G., Yarov-Yarovoy V., Nobbs M., Clare J.J., Scheuer T., Catterall W.A. Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels. Neuropharmacology. 2003; 44 (3): 413-22.Liu G., Yarov-Yarovoy V., Nobbs M., Clare J.J., Scheuer T., Catterall W.A. Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels. Neuropharmacology. 2003; 44 (3): 413-22.Buck T.C., Schmedes A. Brandslund IUgeskr Laeger. 2007 May 21; 169 (21): 2013-5.Buck T.C., Schmedes A. Brandslund IUgeskr Laeger. 2007 May 21; 169 (21): 2013-5.Xie X., Lancaster B., Peakman T., Garthwaite J. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones Pflugers Arch. 1995; 430 (3): 437-46.Xie X., Lancaster B., Peakman T., Garthwaite J. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones Pflugers Arch. 1995; 430 (3): 437-46.Zona C., Tancredi V., Longone P., D’Arcangelo G., D’Antuono M., Manfredi M., Avoli M. Neocortical potassium currents are enhanced by the antiepileptic drug lamotrigine. Epilepsia. 2002; 43 (7): 685-90.Zona C., Tancredi V., Longone P., D’Arcangelo G., D’Antuono M., Manfredi M., Avoli M. Neocortical potassium currents are enhanced by the antiepileptic drug lamotrigine. Epilepsia. 2002; 43 (7): 685-90.

The authors declare that there are no conflicts of interest present.